Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetic cardiomyopathy].

Katashi Okoshi1, Julliano F Campos Guimarães, Bruno Paulino Di Muzio

  • 1Departamento de Clínica Médica, Faculdade de Medicina de Botucatu, UNESP, SP, Brazil. katashi@fmb.unesp.br

Arquivos Brasileiros De Endocrinologia E Metabologia
|May 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Septal Myectomy and Atrial Myxoma Resection: Two Diseases, One Heart, and a Case Report.

The American journal of case reports·2026
Same author

Effects of SGLT2 inhibitor dapagliflozin on the heart of rats with long-standing Type 1 diabetes mellitus: Protein profile.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Septic Cardiac Remodeling: A New Concept in Cardiac Dysfunction Induced by Experimental Sepsis.

Antioxidants (Basel, Switzerland)·2026
Same author

Effects of Early Treatment with Lipid Core Nanoparticles-Associated Methotrexate on Cardiac Remodeling and Soleus Muscle Inflammasomes in Infarcted Rats.

International journal of molecular sciences·2026
Same author

Functional RNA Applications in Cardiovascular Precision Medicine: Advances and Diagnostic Perspectives.

Arquivos brasileiros de cardiologia·2025
Same author

Anti-inflammatory effect of bergamot leaves extract attenuates cardiac remodeling in obese rats by regulating the protein expression of the collagen/metalloproteinase axis.

PloS one·2025

Diabetic cardiomyopathy, a heart condition in diabetes mellitus patients, involves hypertrophy and cell death. Early detection of diastolic dysfunction is possible before heart failure symptoms appear.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pathology

Context:

  • Diabetic cardiomyopathy is a distinct myocardial disease linked to diabetes mellitus.
  • It is independent of vascular, valvular, or hypertensive heart disease.
  • Diabetes mellitus induces significant cardiac changes, including hypertrophy, necrosis, and apoptosis.

Purpose:

  • To elucidate the pathophysiology of diabetic cardiomyopathy.
  • To highlight the clinical manifestations and detection of diabetic cardiomyopathy.
  • To outline current treatment strategies for heart failure in this context.

Summary:

  • Diabetes mellitus triggers metabolic disturbances (hyperlipidemia, hyperglycemia, hyperinsulinemia) affecting cardiac metabolism.
  • These metabolic changes result in oxidative stress, interstitial fibrosis, myocyte death, and impaired calcium homeostasis.

Related Experiment Videos

  • Early asymptomatic diastolic dysfunction is detectable, with systolic dysfunction appearing later in heart failure progression.

    • Impact:

    • Understanding diabetic cardiomyopathy's pathophysiology is crucial for targeted therapeutic development.
    • Early detection of diastolic dysfunction can lead to timely interventions.
    • Standard heart failure guidelines apply, focusing on ventricular function for treatment.